HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS
    91.
    发明公开
    HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS 审中-公开
    包含一种或更多种群EPISENSUS抗原的HIV疫苗

    公开(公告)号:EP3200878A1

    公开(公告)日:2017-08-09

    申请号:EP15847978.2

    申请日:2015-10-05

    IPC分类号: A61P31/18 A61K39/21

    摘要: Provided herein are HIV-1 vaccines comprising a carrier and a population episensus antigen determined using the EpiGraph approach. Also provided are HIV-1 vaccines comprising a carrier, a population episensus antigen, and a tailored antigen. Also provided are methods of designing and producing an HIV-1 vaccine for a subject comprising designing vaccine antigens to optimally cover the diversity within a geographic area using an antigen amino acid sequence generated using the EpiGraph approach, and producing said designed vaccine antigen. Also provided are methods of inducing an effector memory T cell response comprising designing the one or more EpiGraph amino acid sequences, producing a vaccine comprising the one or more EpiGraph amino acid sequences and a vector, and administering the vaccine to a subject. Further provided are methods of treating HIV-1 in a subject comprising administering an effective amount of the described HIV-1 vaccines to the subject in need thereof.

    摘要翻译: 本文提供了使用EpiGraph方法确定的包含载体和群体遗传抗原的HIV-1疫苗。 还提供了包含载体,群体发生抗原和定制抗原的HIV-1疫苗。 还提供了设计和生产用于受试者的HIV-1疫苗的方法,包括使用EpiGraph方法产生的抗原氨基酸序列设计疫苗抗原以最优地覆盖地理区域内的多样性,并产生所述设计的疫苗抗原。 还提供了诱导效应记忆T细胞应答的方法,包括设计一个或多个EpiGraph氨基酸序列,产生包含一个或多个EpiGraph氨基酸序列的疫苗和载体,并将该疫苗给予受试者。 进一步提供了治疗受试者中的HIV-1的方法,其包括将有效量的所述HIV-1疫苗给予有需要的受试者。

    IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY
    93.
    发明公开
    IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY 审中-公开
    IONISCHEFLÜSSIGKEITENZUR TRANSDERMALEN ARZNEIMITTELVERABREICHUNG

    公开(公告)号:EP3062819A2

    公开(公告)日:2016-09-07

    申请号:EP14859243.9

    申请日:2014-11-03

    摘要: IIONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY ABSTRACT The compositions and methods described herein are topically applied to the skin with negligible or no skin irritation and can direct or prevent transport through the skin. The compositions contain neat ionic liquids, optionally in combination with a drug to be delivered. In a preferred embodiment, the compositions increase transdermal transport of the drug to be delivered. In some embodiments, the compositions disrupt bacterial biofilms. This is particularly beneficial in the treatment of antibiotic resistant skin infections. In other embodiments, the compositions direct delivery within the skin. In still other embodiments, the compositions prevent transfer of substances through the stratum corneum. The disclosed compositions and methods can be tuned and modified such that they can be used to treat or prevent a variety of different diseases and disorders.

    摘要翻译: 本文描述的组合物和方法局部施用于具有可忽略或无皮肤刺激性的皮肤,并且可以引导或预防通过皮肤的运输。 组合物含有纯的离子液体,任选地与待递送的药物组合。 在优选的实施方案中,组合物增加待递送药物的透皮转运。 在一些实施方案中,组合物破坏细菌生物膜。 这对抗生素抗性皮肤感染的治疗特别有益。 在其它实施方案中,组合物在皮肤内直接递送。 在其它实施方案中,组合物防止物质通过角质层转移。 所公开的组合物和方法可以被调整和修饰,使得它们可以用于治疗或预防多种不同的疾病和病症。